Aeglea Biotherapeutics shares owned by Assenagon Asset Management
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Assenagon Asset Management
from 13F filings
Historical chart of Assenagon Asset Management investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Assenagon Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Assenagon Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $371k | 22k | 16.76 |
| 2025-06-30 | $331k | 22k | 14.97 |
| 2025-03-31 | $367k | 23k | 16.14 |
| 2024-12-31 | $527k | 23k | 23.28 |
| 2024-09-30 | $34M | 1.1M | 29.41 |
| 2024-03-31 | $2.4M | 64k | 37.93 |
More positions owned by Assenagon Asset Management
View all positions for Assenagon Asset Management